Concepedia

Mary Stevenage

MS

Statistics

Publications

3

Citations

53

H-Index

3

Active since

2020

Affiliations

NIHR Leicester Biomedical Research Centre(Current)

University of Leicester

University of Surrey

Royal Surrey NHS Foundation Trust

Mary Stevenage is an author at NIHR Leicester Biomedical Research Centre specializing in diabetes mellitus, diabetology, and glucose concentration.

Publications per year

2020–2022

3

Publications

3

The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 Diabetes

Roselle Herring, Fariba Shojaee‐Moradie, Mary Stevenage et al. · Diabetes Care · 2022 · 26 citations · Full text

, , +17

Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes

Roselle Herring, Fariba Shojaee‐Moradie, Robert Garesse et al. · Diabetes Care · 2020 · 16 citations · Full text

, , +17

Effect of Dapagliflozin on Cardiac Function and Metabolic and Hormonal Responses to Exercise

Roselle Herring, Iain Parsons, Fariba Shojaee‐Moradie et al. · The Journal of Clinical Endocrinology & Metabolism · 2022 · 11 citations

, , +17

1–3 of 3